Skip to main content

Advertisement

SpringerLink
Log in

Integrin αvβ3 targeting activity study of different retro-inverso sequences of RGD and their potentiality in the designing of tumor targeting peptides

  • Original Article
  • Published:
Amino Acids Aims and scope Submit manuscript

Abstract

Retro-inverso peptide represented the isomer of a parent peptide in which the direction of the sequence was reversed and the chirality of each amino acid residue was inverted. Generally, retro-inverso peptides possessed equal or even higher activities compared to the original peptide. RGD was a commonly used ligand for tumor and vascular targeting due to its affinity to integrin αvβ3 receptors. The biological activity study of the isomers of RGD would indeed provide useful suggestions for the design of tumor targeting peptides. Therefore, the tumor targeting activities of octa-arginine which was modified with different retro-inverso sequences of RGD peptide were investigated in this study. Three different tandem peptides (R8-GDGR, R8-GdGr and R8-GdGR) were designed on the basis of R8-GRGD. The tumor targeting activities of these tandem peptides were evaluated both in vitro and in vivo. Finally, R8-GdGR displayed selective binding affinity to integrin αvβ3 at the cellular level, and exhibited efficient tumor homing and penetrating capabilities in vivo. Meanwhile, R8-GdGR also showed stronger neovessel targeting ability compared to the others. In conclusion, all the results demonstrated that dGR possessed similar biological activity to RGD and was a potential ligand for further designing of tumor targeting peptides.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Abraham T, Prenner EJ, Lewis RN, Mant CT, Keller S, Hodges RS, McElhaney RN (2014) Structure–activity relationships of the antimicrobial peptide gramicidin S and its analogs: aqueous solubility, self-association, conformation, antimicrobial activity and interaction with model lipid membranes. Biochim Biophys Acta 1838(5):1420–1429

    Article  CAS  PubMed  Google Scholar 

  • Alberici L, Roth L, Sugahara KN, Agemy L, Kotamraju VR, Teesalu T, Bordignon C, Traversari C, Rizzardi G-P, Ruoslahti E (2013) De novo design of a tumor-penetrating peptide. Cancer Res 73(2):804–812

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Barczyk M, Carracedo S, Gullberg D (2010) Integrins. Cell Tissue Res 339(1):269–280

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Bernstein H-G, Dobrowolny H, Trübner K, Steiner J, Bogerts B, Hoffmann W (2015) Differential regional and cellular distribution of TFF3 peptide in the human brain. Amino Acids 47(5):1053–1063

    Article  CAS  PubMed  Google Scholar 

  • Choi KY, Chung H, Min KH, Yoon HY, Kim K, Park JH, Kwon IC, Jeong SY (2010) Self-assembled hyaluronic acid nanoparticles for active tumor targeting. Biomaterials 31(1):106–114

    Article  CAS  PubMed  Google Scholar 

  • Contois LW, Akalu A, Caron JM, Tweedie E, Cretu A, Henderson T, Liaw L, Friesel R, Vary C, Brooks PC (2015) Inhibition of tumor-associated αvβ3 integrin regulates the angiogenic switch by enhancing expression of IGFBP-4 leading to reduced melanoma growth and angiogenesis in vivo. Angiogenesis 18(1):31–46

    Article  CAS  PubMed  Google Scholar 

  • Dearling JL, Barnes JW, Panigrahy D, Zimmerman RE, Fahey F, Treves ST, Morrison MS, Kieran MW, Packard AB (2013) Specific uptake of 99m Tc-NC100692, an α v β 3-targeted imaging probe, in subcutaneous and orthotopic tumors. Nucl Med Biol 40(6):788–794

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Desgrosellier JS, Cheresh DA (2010) Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 10(1):9–22

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Gao H, Xiong Y, Zhang S, Yang Z, Cao S, Jiang X (2014) RGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetration. Mol Pharm 11(3):1042–1052

    Article  CAS  PubMed  Google Scholar 

  • Gentilucci L, Cardillo G, Spampinato S, Tolomelli A, Squassabia F, De Marco R, Bedini A, Baiula M, Belvisi L, Civera M (2009) Antiangiogenic effect of dual/selective α5β1/αvβ3 integrin antagonists designed on partially modified retro-inverso cyclotetrapeptide mimetics. J Med Chem 53(1):106–118

    Article  Google Scholar 

  • Goel HL, Mercurio AM (2012) Enhancing integrin function by VEGF/neuropilin signaling: implications for tumor biology. Cell Adh Migr 6(6):554–560

    Article  PubMed Central  PubMed  Google Scholar 

  • Goodman M, Chorev M (1979) On the concept of linear modified retro-peptide structures. Acc Chem Res 12(1):1–7

    Article  CAS  Google Scholar 

  • Graf N, Bielenberg DR, Kolishetti N, Muus C, Banyard J, Farokhzad OC, Lippard SJ (2012) αVβ3 integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrug. ACS Nano 6(5):4530–4539

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Guo Z, He B, Jin H, Zhang H, Dai W, Zhang L, Zhang H, Wang X, Wang J, Zhang X (2014) Targeting efficiency of RGD-modified nanocarriers with different ligand intervals in response to integrin αvβ3 clustering. Biomaterials 35(23):6106–6117

    Article  CAS  PubMed  Google Scholar 

  • Kibria G, Hatakeyama H, Ohga N, Hida K, Harashima H (2011) Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery. J Control Release 153(2):141–148

    Article  CAS  PubMed  Google Scholar 

  • Kiugel M, Dijkgraaf I, Kytö V, Helin S, Liljenbäck H, Saanijoki T, Yim C-B, Oikonen V, Saukko P, Knuuti J (2014) Dimeric [68Ga] DOTA-RGD peptide targeting αvβ3 integrin reveals extracellular matrix alterations after myocardial infarction. Mol Imaging Biol 16(6):793–801

    Article  PubMed  Google Scholar 

  • Leblanc R, Lee S, David M, Bordet J, Norman D, Patil R, Miller D, Sahay D, Ribeiro J, Clézardin P (2014) Interaction of platelet-derived autotaxin with tumor integrin αVβ3 controls metastasis of breast cancer cells to bone. Blood 124(20):3141–3150

    Article  CAS  PubMed  Google Scholar 

  • Li Y, Lei Y, Wagner E, Xie C, Lu W, Zhu J, Shen J, Wang J, Liu M (2013) Potent retro-inverso D-peptide for simultaneous targeting of angiogenic blood vasculature and tumor cells. Bioconjug Chem 24(1):133–143

    Article  PubMed  Google Scholar 

  • Lim J, Pellois J-P, Simanek EE (2010) A retro-inverso TAT-like peptide designed to deliver cysteamine to cells. Bioorg Med Chem Lett 20(21):6321–6323

    Article  CAS  PubMed  Google Scholar 

  • Liu Y, Ran R, Chen J, Kuang Q, Tang J, Mei L, Zhang Q, Gao H, Zhang Z, He Q (2014) Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting. Biomaterials 35(17):4835–4847

    Article  CAS  PubMed  Google Scholar 

  • Maeda H (2015) Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity. Adv Drug Deliv Rev. doi:10.1016/j.addr.2015.01.002

    PubMed  Google Scholar 

  • Magnon C, Galaup A, Mullan B, Rouffiac V, Bidart J-M, Griscelli F, Opolon P, Perricaudet M (2005) Canstatin acts on endothelial and tumor cells via mitochondrial damage initiated through interaction with αvβ3 and αvβ5 integrins. Cancer Res 65(10):4353–4361

    Article  CAS  PubMed  Google Scholar 

  • Mingozzi M, Manzoni L, Arosio D, Dal Corso A, Manzotti M, Innamorati F, Pignataro L, Lecis D, Delia D, Seneci P (2014) Synthesis and biological evaluation of dual action cyclo-RGD/SMAC mimetic conjugates targeting α v β 3/α v β 5 integrins and IAP proteins. Org Biomol Chem 12(20):3288–3302

    Article  CAS  PubMed  Google Scholar 

  • Nie L, Wang S, Wang X, Rong P, Ma Y, Liu G, Huang P, Lu G, Chen X (2014) In vivo volumetric photoacoustic molecular angiography and therapeutic monitoring with targeted plasmonic nanostars. Small 10(8):1585–1593

    Article  CAS  PubMed  Google Scholar 

  • Pang H-B, Braun GB, Friman T, Aza-Blanc P, Ruidiaz ME, Sugahara KN, Teesalu T, Ruoslahti E (2014) An endocytosis pathway initiated through neuropilin-1 and regulated by nutrient availability. Nat Commun. doi:10.1038/ncomms5904

  • Qin Y, Chen H, Yuan W, Kuai R, Zhang Q, Xie F, Zhang L, Zhang Z, Liu J, He Q (2011) Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery. Int J Pharm 419(1):85–95

    Article  CAS  PubMed  Google Scholar 

  • Seguin L, Desgrosellier JS, Weis SM, Cheresh DA (2015) Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. Trends Cell Biol. doi:10.1016/j.tcb.2014.12.006

    PubMed  Google Scholar 

  • Shattil SJ, Kim C, Ginsberg MH (2010) The final steps of integrin activation: the end game. Nat Rev Mol Cell Biol 11(4):288–300

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Staykova ST, Wesselinova DW, Vezenkov LT, Naydenova ED (2015) Synthesis and in vitro antitumor activity of new octapeptide analogs of somatostatin containing unnatural amino acids. Amino Acids 47(5):1007–1013

    Article  CAS  PubMed  Google Scholar 

  • Sugahara KN, Teesalu T, Karmali PP, Kotamraju VR, Agemy L, Girard OM, Hanahan D, Mattrey RF, Ruoslahti E (2009) Tissue-penetrating delivery of compounds and nanoparticles into tumors. Cancer Cell 16(6):510–520

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Taylor EM, Otero DA, Banks WA, O’Brien JS (2000) Retro-inverso prosaptide peptides retain bioactivity, are stable In vivo, and are blood-brain barrier permeable. J Pharmacol Exp Ther 295(1):190–194

    CAS  PubMed  Google Scholar 

  • Teesalu T, Sugahara KN, Kotamraju VR, Ruoslahti E (2009) C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration. Proc Natl Acad Sci 106(38):16157–16162

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Trabocchi A, Menchi G, Danieli E, Potenza D, Cini N, Bottoncetti A, Raspanti S, Pupi A, Guarna A (2010) Cyclic DGR-peptidomimetic containing a bicyclic reverse turn inducer as a selective αvβ5 integrin ligand. Amino Acids 38(1):329–337

    Article  CAS  PubMed  Google Scholar 

  • Vachutinsky Y, Oba M, Miyata K, Hiki S, Kano MR, Nishiyama N, Koyama H, Miyazono K, Kataoka K (2011) Antiangiogenic gene therapy of experimental pancreatic tumor by sFlt-1 plasmid DNA carried by RGD-modified crosslinked polyplex micelles. J Control Release 149(1):51–57

    Article  CAS  PubMed  Google Scholar 

  • Wang J, Lei Y, Xie C, Lu W, Wagner E, Xie Z, Gao J, Zhang X, Yan Z, Liu M (2014) Retro-inverso CendR peptide-mediated polyethyleneimine for intracranial glioblastoma-targeting gene therapy. Bioconjug Chem 25(2):414–423

    Article  CAS  PubMed  Google Scholar 

  • Wermuth J, Goodman S, Jonczyk A, Kessler H (1997) Stereoisomerism and biological activity of the selective and superactive αvβ3 integrin inhibitor cyclo (-RGDfV-) and its retro-inverso peptide. J Am Chem Soc 119(6):1328–1335

    Article  CAS  Google Scholar 

  • Winograd-Katz SE, Fässler R, Geiger B, Legate KR (2014) The integrin adhesome: from genes and proteins to human disease. Nat Rev Mol Cell Biol 15(4):273–288

    Article  CAS  PubMed  Google Scholar 

  • Yan H, Wang L, Wang J, Weng X, Lei H, Wang X, Jiang L, Zhu J, Lu W, Wei X (2011) Two-order targeted brain tumor imaging by using an optical/paramagnetic nanoprobe across the blood brain barrier. ACS Nano 6(1):410–420

    Article  PubMed  Google Scholar 

  • Yang G, Sun H, Kong Y, Hou G, Han J (2014) Diversity of RGD radiotracers in monitoring antiangiogenesis of flavopiridol and paclitaxel in ovarian cancer xenograft-bearing mice. Nucl Med Biol 41(10):856–862

    Article  CAS  PubMed  Google Scholar 

  • YoungáChoi K, HyunáMin K, HeeáNa J, ChanáKwon I, YoungáJeong S (2009) Self-assembled hyaluronic acid nanoparticles as a potential drug carrier for cancer therapy: synthesis, characterization, and in vivo biodistribution. J Mater Chem 19(24):4102–4107

    Article  Google Scholar 

  • Zhang Q, Tang J, Fu L, Ran R, Liu Y, Yuan M, He Q (2013) A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system. Biomaterials 34(32):7980–7993

    Article  CAS  PubMed  Google Scholar 

  • Zheng Y, Ji S, Czerwinski A, Valenzuela F, Pennington M, Liu S (2014) FITC-conjugated cyclic RGD peptides as fluorescent probes for staining integrin αvβ3/αvβ5 in tumor tissues. Bioconjug Chem 25(11):1925–1941

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The work was funded by the National Basic Research Program of China (973 Program, 2013CB932504), and the National Natural Science Foundation of China (81373337).

Author information

Authors and Affiliations

  1. Key Laboratory of Drug Targeting and Drug Delivery Systems, West China School of Pharmacy, Sichuan University, No. 17, Block 3, Southern Renmin Road, Chengdu, 610041, China

    Yayuan Liu, Ling Mei, Qianwen Yu, Qianyu Zhang, Huile Gao, Zhirong Zhang & Qin He

Authors
  1. Yayuan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ling Mei
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qianwen Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qianyu Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Huile Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zhirong Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Qin He
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Qin He.

Ethics declarations

Conflict of interest

We declare that we have no financial and personal relationships with other people or organizations that can inappropriately influence our work and that there is no professional or other personal interest of any nature or kind in any product, service and/or company that could be construed as influencing the position presented in the manuscript.

Additional information

Handling Editor: J. D. Wade.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, Y., Mei, L., Yu, Q. et al. Integrin αvβ3 targeting activity study of different retro-inverso sequences of RGD and their potentiality in the designing of tumor targeting peptides. Amino Acids 47, 2533–2539 (2015). https://doi.org/10.1007/s00726-015-2043-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00726-015-2043-9

Keywords

Search

Navigation